Resumen de acción DXCM
DexCom, Inc. es una empresa de dispositivos médicos dedicada al diseño, desarrollo y comercialización de sistemas de monitorización continua de la glucosa (MCG) en Estados Unidos y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de DexCom, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$124.34 |
| 52 Week High | US$142.00 |
| 52 Week Low | US$74.75 |
| Beta | 1.21 |
| 1 Month Change | -10.85% |
| 3 Month Change | 1.95% |
| 1 Year Change | 2.47% |
| 3 Year Change | 28.82% |
| 5 Year Change | 304.52% |
| Change since IPO | 4,136.46% |
Noticias y actualizaciones recientes
Recent updates
Returns At DexCom (NASDAQ:DXCM) Are On The Way Up
Apr 25
Why We're Not Concerned About DexCom, Inc.'s (NASDAQ:DXCM) Share Price
Apr 12DexCom Is Pricey For A Reason - Its Growth Story Reflects That
Apr 11Is DexCom (NASDAQ:DXCM) Using Too Much Debt?
Mar 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Mar 04DexCom: A Wealth Compounder In Healthcare
Feb 14DexCom: Stelo Stellar Outlook
Jan 17DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital
Jan 15DexCom, Inc. (NASDAQ:DXCM) Not Lagging Industry On Growth Or Pricing
Jan 01DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Dec 18A Look At The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Dec 05At US$109, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?
Nov 21DexCom (NASDAQ:DXCM) Is Looking To Continue Growing Its Returns On Capital
Sep 28DexCom (NASDAQ:DXCM) Could Easily Take On More Debt
Sep 13Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Aug 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Aug 14DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet
Jun 05There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital
May 16Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?
Mar 21These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely
Mar 03DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price
Feb 13DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly
Nov 25Returns Are Gaining Momentum At DexCom (NASDAQ:DXCM)
Oct 21Dexcom launches G7 glucose monitoring system in parts of Europe, Asia
Oct 04What Is DexCom, Inc.'s (NASDAQ:DXCM) Share Price Doing?
Sep 24DexCom: A High-Priced Medical Devices Company Remains Stuck In A Downtrend
Sep 21DexCom promotes technology chief Leach to COO
Aug 31DexCom (NASDAQ:DXCM) Has A Pretty Healthy Balance Sheet
Aug 01DexCom stock down ~7% after hours as Q2 results miss expectations
Jul 28Estimating The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)
Jul 13DexCom: I Wouldn't Buy The Dip
Jul 07Is It Time To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?
Jun 24We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)
Jun 03DexCom: Q1'22 Earnings Strong Enough To Maintain Valuation But Not To Increase It
May 01Rentabilidad de los accionistas
| DXCM | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | -4.9% | 2.1% | 2.9% |
| 1Y | 2.5% | -1.9% | 22.2% |
Rentabilidad vs. Industria: DXCM superó al sector US Medical Equipment , que obtuvo un rendimiento del -0.5% el año pasado.
Rentabilidad vs. Mercado: DXCM obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| DXCM volatility | |
|---|---|
| DXCM Average Weekly Movement | 5.8% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: DXCM no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de DXCM (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1999 | 9,550 | Kevin Sayer | www.dexcom.com |
DexCom, Inc. es una empresa de dispositivos médicos dedicada al diseño, desarrollo y comercialización de sistemas de monitorización continua de la glucosa (MCG) en Estados Unidos y a escala internacional. La empresa ofrece sus sistemas a personas con diabetes y a profesionales sanitarios. Sus productos incluyen Dexcom G6 y Dexcom G7, sistemas integrados de MCG para el control de la diabetes; Dexcom Share, un sistema de monitorización remota; Dexcom Real-Time API, que permite a los desarrolladores de software autorizados integrar datos de MCG en tiempo real en sus aplicaciones y dispositivos de salud digital; y Dexcom ONE, que está diseñado para reemplazar las pruebas de glucosa en sangre con punción digital para las decisiones de tratamiento de la diabetes.
Resumen de fundamentos de DexCom, Inc.
| Estadísticas fundamentales de DXCM | |
|---|---|
| Capitalización bursátil | US$49.45b |
| Beneficios(TTM) | US$639.30m |
| Ingresos (TTM) | US$3.80b |
77.3x
Ratio precio-beneficio (PE)13.0x
Ratio precio-ventas (PS)¿Está DXCM sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DXCM | |
|---|---|
| Ingresos | US$3.80b |
| Coste de los ingresos | US$1.41b |
| Beneficio bruto | US$2.39b |
| Otros gastos | US$1.75b |
| Beneficios | US$639.30m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 1.61 |
| Margen bruto | 62.82% |
| Margen de beneficio neto | 16.82% |
| Ratio deuda/patrimonio | 108.4% |
¿Cómo se ha desempeñado DXCM a largo plazo?
Ver rendimiento histórico y comparativa